Northern Trust’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Northern Trust’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-286,031	Closed	-$9.53M	–	4549
2024 Q3	$9.53M	Buy	286,031 +73,100	+34%	+$2.52M	﹤0.01%	2092
2024 Q2	$5.76M	Sell	212,931 -6,492	-3%	-$128K	﹤0.01%	2324
2024 Q1	$4.74M	Buy	219,423 +66,592	+44%	+$1.45M	﹤0.01%	2491
2023 Q4	$922K	Buy	152,831 +15,922	+12%	+$79.3K	﹤0.01%	3340
2023 Q3	$761K	Buy	136,909 +2,762	+2%	+$17.8K	﹤0.01%	3381
2023 Q2	$985K	Buy	134,147 +116,357	+654%	+$881K	﹤0.01%	3369
2023 Q1	$71.3K	Buy	+17,790	New	+$86.9K	﹤0.01%	4171

Northern Trust's LBPH Position: Q4 2024 in Review

Northern Trust sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 286,031 shares — an estimated $9.53M sold.

Northern Trust first reported a position in LBPH in Q1 2023 and held it in 7 quarters. The position peaked at $9.53M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Northern Trust reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Northern Trust sold 286,031 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $9.53M.
Northern Trust first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2023 and held it in 7 quarters.
Northern Trust's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $9.53M in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Northern Trust's 13F filing for Q4 2024, filed 14 Feb 2025.